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INTRODUCTION
Colorectal cancer (CRC) is the fourth most
prevalent cancer in the world and occupies the
second most prevalent in the United States.1 The mean
age of CRC patients in the United States is 67 years.2
The incidence of CRC is highly varied between one
country and another. The number of CRC incidence
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Background: Colorectal cancer (CRC) is the fourth most prevalent cancer in the world and is
positioned the second most common cancer in the United States. Patients with CRC in Indonesia showed
a greater proportion. In Jakarta, 47.85% of CRC cases occur under the age of 45 years. The purpose of
this study was to determine metastasis and the factors that influence CRC patients.
Method: This study was conducted retrospectively from January 2003-December 2007 in Cipto
Mangunkusumo hospital. Patients are eligible if they underwent colonoscopy, tumor biopsy, anatomical
pathology, abdominal CT scan, abdominal ultrasonography, and radiology procedures.
Results: Of all 1,615 patients who underwent colonoscopy procedure, 377 patients were diagnosed
with colorectal cancer. Subject that met the criteria consisted of 86 patients, where 56 (65.1%) male.
The most aged was 51-60 years old (26.7%), mean age 47.90 ± 14.53 years old. The tumor is most
commonly located in the rectum and sigmoid 40 (46.5%), in which 18 (45%) among them had
metastasized. Compared with male patients, female patients experienced more metastases, but not
statistically significant. Among the patients with metastasized CRC, 42.3% of them < 40 years old, 37.2%
patients were 41-60 years old, and 29.4% patients > 60 years old. Well-differentiated CRC produced
larger number of metastatic cases than poorly-differentiated CRC. Poorly-differentiated CRC tended to
produce adjacent metastasis, and also happened in relatively young age in compared with well-
differentiated cancer.
 Conclusion: There was significant correlation between younger age group with a poor degree of
histopathologic differentiation. Patients with CRC consist of more male patients than female ones.
Factors sex, age group, histopathologic subtypes, and tumor location was not associated with metastasis.
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in industrial countries such as USA, Canada, England,
Western Europe, and Australia is higher than that in
regions such as Asia, Africa, and South America.3
The incidence of CRC in Asian countries seem to have
rapidly increased in the last decades.4 According to
Western literature, the prevalence of CRC at the age
below 50 years was 2.8%.5 Almost 147,000 new cases
and ± 57,000 deaths due to CRC occurred in USA
during the year in 2004. Almost 10% of all cancer
incidences in the world are CRC, with similar
prevalence between males and females.6 Patients with
CRC in Indonesia showed a different proportion.
In Jakarta, for instance at age below 45 years are
47.85% of cases.7
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METHOD 
This study was conducted retrospectively for 5 years  
from January 2003 to December 2007 in Cipto  
Mangunkusumo hospital, Jakarta, by collecting  
medical records of patients who underwent  
colonoscopy, biopsy, and anatomical pathology  
procedures. Patients are eligible if they underwent  
colonoscopy, tumor biopsy, anatomical pathology,  
abdominal CT scan, abdominal ultrasound, and  
radiology examinations. Adjacent metastasis is those  
found in periaorta/abdominal lymph nodes. Distant  
metastasis are those found in the liver, lungs, bones,  
and pelvic organs. Patients are excluded if  
the medical data were not complete. 
Statistical analysis using univariate method to 
determine the distribution of CRC incidence, bivariate 
method using Chi-square, and p < 0.05 indicates 
significant result. 
 
RESULTS 
Patients who underwent colonoscopy procedure are  
1,615 subjects, consisting of 377 patients with CRC  
and 1,238 patients without CRC. Of the 377 patients  
with CRC, 86 patients met the inclusion criteria. Based  
on the sex, consisted of 56 (65.1%) male and  
30 (34.9%) female. Most age above 51 years old were  
40 (46.5%) patients, and the mean age of 47.90 ± 14.53  
years. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on the location the tumor was highly found  
in rectum and sigmoid 40 (46.5%) cases, and these  
were the ones most frequently progressed to  
metastasis which occurred in 18 (45.0%) cases  
(table 1). 
 
Table 1. Metastasis and tumor location 
No 
Tumor location metastasis   Metastasis n p 
n (%) n (%) 
Ascending colon 14 (73.7) 5 (26.3) 19 0.493 
Transversal colon 9 (64.3) 5 (35.7) 14 
Descending colon 9 (69.2) 4 (30.8) 13 
Rectum and sigmoid 22 (55.0) 18 (45.0) 40 
The male patients show higher number of cases 
without metastasis, while the females show relatively  
higher number of adjacent metastasis and distant  
metastasis. This result was not statistically significant  
(figure 2). 
In this study, patients with metastasized CRC based 
on age group were 11 patients < 40 years old, 
16 patients between 41-60 years old, 5 patients > 
60 years old. However, this difference was not 
statistically significant (figure 3). 
Based on histopathological differentiation was found 
that the well-differentiated cancer showed slightly 
higher number of cases of distant metastasis than the 
poorly-differentiated. Meanwhile, cases with no 
metastasis and adjacent metastasis were slightly higher in 
poorly-differentiated cancer (table 2). 
 
 
 
 
 
 
 
 
 
In this study also found that group of poorly- 
differentiated cancer is more frequent in relatively  
young age group compared with well-differentiated.  
This correlation was statistically significant (p < 0.05)  
table 3).  
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Table 2. The distribution of metastasis based on anatomical 
pathology 
 
 
Well-
differentiated 
Poorly-
differentiated n 
n (%) n (%) 
No metastasis 23 (62.2) 32 (65.3) 55 
Distant metastasis 11 (29.7) 12 (24.48) 23 
Adjacent metastasis 3 (8.1) 5 (10.2) 8 
Total 37 49 86 
 
Figure 1. Age distribution of CRC patients 
39
16 12
11
5
3
0
10
20
30
40
n
 p
a
ti
e
n
ts
No
metastasis
Distant
metastasis
Adjacent
metastasis
Males Females
Figure 2. Metastasis based on sex 
Figure 3. Metastasis based on age group 
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Table 3. Anatomical pathology based on mean of age 
 n Mean of age SD p 
Well-differentiated 37 52.30 14.44 0.014* 
Poorly-differentiated 49 44.57 13.82 
* significant 
DISCUSSION
In this study, it was found that the CRC patients
consist of 56 (65%) male and of 30 (34%) females
with a ratio of 1.9 : 1. According to Chandler, CRC
incidence does not highly differ between males and
females (1.2:1).8 The incidence of CRC in this study
is 23.3%. Study by Chong et al, reported the incidence
of CRC as 7.4%.9 Moreover, study by Tamura et al
from Japan reported that it was 42.5 males and 25.6
females per 100,000 population.10 According to the
location of the tumors found mostly in the rectum and
sigmoid (46.5%). This result is similar to reports by
Tamura et al from Japan.10
In this study, the mean age of patients with CRC
was 51-60 years old, which consisted of 23 (26.7%)
patients. In Italy, Bertoglio et al reported their study
from February 1999 to January 2003 found 26 cases
of CRC was identified, which consists of 14 males
and 12 females with age range 48-76 years.11
Based on sex, male patients with no metastasis were
more prevalent than female patients. Meanwhile,
patients with distant and adjacent metastasis consisted
of slightly more females than males. CRC patients who
experienced metastasis consist of relatively higher
number of patients in the age group < 40 years old
than the age group of 41-60 years old and > 60 years
old. For comparison, Minardi et al reported that
the young CRC patients was found in higher number
between cases of advanced stage (Dukes C and D)
with low 5-year survival rate.12
Based on the degree of histopathological
differentiation, well-differentiated cases which
experienced distant metastasis were found slightly
higher compared to poorly-differentiated ones.
Meanwhile, no metastasis and adjacent metastasis
were found slightly higher in poorly-differentiated
cases compared to well-differentiated ones.
In this study, factors of sex, age group, and
the degree of histopathological differentiation were
correlated to metastasis, but the effect was not
statistically significant. The important factor which
determines long-term result of CRC if there is
a metastasis in local lymph nodes (adjacent
metastasis). Lymph nodes are involved in stage II
CRC.13
Liver is the second most frequent organ to be
involved in CRC metastasis after the lymph nodes.
In Europe and US, lesions in the liver most frequently
describe metastasis rather than primary malignancy.14
According to Donald et al, when first identified, less
than a quarter of CRC patients had occurred  in
the liver metastases (distant metastasis), and
the presence or absence of liver metastasis was the
starting point which determines survival.15
This study also measured the correlation between
the degree of histopathologic differentiation and
the mean of age. It was discovered that the poorly-
differentiated degree was found more in the relatively
young age (44.5 ± 13.82 years) compared to the well-
differentiated ones (52.30 ± 14.44 years). This
correlation was statistically significant (p < 0.05).
In this studied identified 37 (43%) patients with
well-differentiated cases and 49 (57%) patients with
poorly differentiated cases. Study in the UK,
Chandler et al reported on 7 cases of CRC, 35% was
identified as well-differentiated, and 48% was
identified as poorly-differentiated.8
Similarly, a study of 19 CRC cases, which
consisted of 14% of well-differentiated, 42% of
moderate, and 44% of poorly-differentiated. Study by
Kaneko et al reported that CRC patients in which
metastasis had spread to the lymph node around
perirectal area, inferior mesenterics, and periaortal
area, were approximately 55%.16
CONCLUSION
From the result of this study, a significant
correlation was found between the rate of younger
age and the poor degree of histopathologic differen-
tiation. Patients with CRC consisted of males more
than females. Factors sex, age group, histopatho-
logical subtypes, and tumor location were not
associated with metastasis.
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